185434-43-9Relevant articles and documents
Design and synthesis of novel CCR3 antagonists
Gong, Leyi,Hogg, J. Heather,Collier, James,Wilhelm, Robert S.,Soderberg, Carol
, p. 3597 - 3600 (2007/10/03)
As part of our investigation into the development of potent CCR3 antagonists, a series of piperidine analogues was designed and prepared. Exploration of the piperidine core examined both the basicity and the location of a nitrogen, as well as conformational variants. The bicyclo-piperidine 24c was found to be the most potent inhibitor of CCR3 with an IC50 of 0.0082 μM in the binding assay and 0.0024 μM in the chemotaxis assay.
Cyclic amine derivatives-CCR-3 receptor antagonists
-
Page column 63, (2010/01/31)
This invention relates to certain cyclic amine derivatives of Formula (I) that are CCR-3 receptor antagonist, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
Cyclic amine derivatives- CCR-3 receptor antagonists
-
, (2008/06/13)
This invention relates to certain cyclic amine derivatives of Formula (I) that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]-1- benzylpiperidine for the dopamine transporter: Effect of different aromatic substitutions on their affinity and selectivity
Dutta, Aloke K.,Coffey, Lori L.,Reith, Maarten E. A.
, p. 35 - 43 (2007/10/03)
Several analogs of the potent and selective dopamine transporter (DAT) ligand 4-[2(diphenylmethoxy)ethyl]-1-benzylpiperidine, 1a, were prepared and biologically evaluated at the dopamine and serotonin transporter (SERT) sites. Several substituents were in